Whitney Notaro | executive |
Scott Wagner | executive |
Karsten Voermann | executive |
Michael Cherny | analyst |
Jailendra Singh | analyst |
Stephanie Davis | analyst |
Daniel Grosslight | analyst |
Lisa Gill | analyst |
Charles Rhyee | analyst |
Stanislav Berenshteyn | analyst |
Scott Schoenhaus | analyst |
Mitchell Ostrovsky | analyst |
Sean Dodge | analyst |
Allen Lutz | analyst |
John Ransom | analyst |
John Park | analyst |
George Hill | analyst |
Ladies and gentlemen, thank you for standing by and welcome to the GoodRx First Quarter 2024 Earnings Call. At this time a reminder today's conference is being recorded. I will now like to introduce your host for today's call; Whitney Notaro, Vice President of Investor Relations. Ms. Notaro, you may begin.